Shilajit Extract 100 mg Extra Strength

Stronger ingredient identification and complementary actives may make it more useful when mitochondrial or performance support is also wanted. It combines 100 mg of PrimaVie shilajit with 100 mg of ubiquinol in a fat-containing softgel, which broadens mitochondrial support; CoQ10 may reduce warfarin’s anticoagulant effect.

Stronger ingredient identification and complementary actives may make it more useful when mitochondrial or performance support is also wanted. Purified organic PrimaVie shilajit is paired with 150 mg of branded ubiquinol and 10 mg of PQQ, though the dry capsule lacks a lipid carrier and CoQ10 may interact with warfarin.

A substantial branded shilajit amount and clearly identified supporting actives broaden performance support. The formula combines 200 mg of PrimaVie shilajit with well-identified ashwagandha, tongkat ali, zinc, and piperine; regular use warrants attention to copper-free zinc and possible piperine interactions.

It lowers the supplied per-serving cost while keeping shilajit central to the formula. The focused extract lists 400 mg with fulvic-acid and mineral-pitch wording, though the duplicated label and missing contaminant-testing details limit certainty.

It lowers the supplied per-serving cost while keeping shilajit central to the formula. A 250 mg Himalayan shilajit extract keeps the formula focused, but fulvic-acid standardization, purification details, and contaminant testing are not supplied.

It lowers the supplied per-serving cost while keeping shilajit central to the formula. The 250 mg fulvic-acid complex is purpose-built for shilajit use, although its fulvic-acid percentage, purification details, and contaminant testing are not supplied.

A lower supplied serving cost and a practical shilajit-focused profile improve the quality-to-cost balance. The simple 250 mg shilajit serving is plausible for routine use, but standardization, purification, source form, and contaminant testing are not supplied.

The serving cost is not lower in the supplied data, but the formula offers a useful quality-to-cost trade-off among the remaining distinct choices. A focused 400 mg serving provides a practical shilajit amount, while missing standardization, purification, source-form, and contaminant-testing details remain important limits.

A lower supplied serving cost and a practical shilajit-focused profile improve the quality-to-cost balance. PrimaVie shilajit and ubiquinol are each supplied at 50 mg for a modest maintenance formula; CoQ10 may reduce warfarin’s anticoagulant effect.